Antibiotice Ia (RO:ATB) — Stock Price
Antibiotice Ia (RO:ATB) is currently trading at RON2.13 RON, down 0.93% today. Over the past 52 weeks, shares have ranged between RON1.77 and RON2.63. This page tracks Antibiotice Ia's live share price on the RO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Antibiotice Ia (ATB) total market value.
Antibiotice Ia (ATB) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Antibiotice Ia's daily closing share price and trading volume on the RO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Antibiotice Ia Income Statement — Revenue, Profit & Earnings by Year
Antibiotice Ia's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | RON645.28 Million | RON675.01 Million | RON600.78 Million | RON483.72 Million | RON366.21 Million |
| Cost of Revenue | RON222.41 Million | RON223.00 Million | RON191.38 Million | RON151.65 Million | RON136.42 Million |
| Gross Profit | RON422.87 Million | RON452.01 Million | RON409.40 Million | RON332.08 Million | RON229.79 Million |
| Research & Development | — | — | — | — | — |
| SG&A | RON30.35 Million | RON32.39 Million | RON27.65 Million | RON35.48 Million | RON11.01 Million |
| Total Operating Expenses | RON584.05 Million | RON571.05 Million | RON502.42 Million | RON412.86 Million | RON336.86 Million |
| Operating Income | RON61.23 Million | RON103.96 Million | RON98.36 Million | RON70.87 Million | RON29.35 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | RON4.47 Million | RON4.54 Million | RON4.15 Million | RON3.59 Million | RON3.52 Million |
| Income Before Tax | RON60.15 Million | RON103.11 Million | RON91.52 Million | RON65.31 Million | RON30.30 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | RON51.77 Million | RON102.20 Million | RON81.09 Million | RON51.47 Million | RON29.94 Million |
Antibiotice Ia Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Antibiotice Ia's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | RON1.39 Billion | RON1.28 Billion | RON1.14 Billion | RON856.47 Million | RON895.39 Million |
| Total Current Assets | RON505.69 Million | RON474.69 Million | RON401.28 Million | RON323.87 Million | RON385.01 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | RON339.09 Million | RON311.94 Million | RON249.29 Million | RON204.03 Million | RON269.76 Million |
| Inventory | RON182.34 Million | RON169.86 Million | RON160.21 Million | RON122.49 Million | RON106.02 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | RON460.49 Million | RON384.95 Million | RON292.21 Million | RON215.04 Million | RON290.40 Million |
| Total Current Liabilities | RON250.36 Million | RON235.06 Million | RON190.47 Million | RON135.34 Million | RON199.14 Million |
| Long-term Debt | RON135.74 Million | RON85.72 Million | RON36.75 Million | RON46.97 Million | RON57.62 Million |
| Net Debt | RON223.54 Million | RON138.03 Million | RON64.49 Million | RON79.25 Million | RON142.67 Million |
| Total Stockholder Equity | RON932.07 Million | RON894.31 Million | RON846.96 Million | RON641.43 Million | RON604.99 Million |
| Retained Earnings | RON221.23 Million | RON201.07 Million | RON229.53 Million | RON-40.16 Million | RON-46.58 Million |
Antibiotice Ia Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Antibiotice Ia generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | RON72.44 Million | RON95.15 Million | RON122.46 Million | RON115.66 Million |
| Capital Expenditures | RON142.61 Million | RON116.16 Million | RON98.04 Million | RON39.88 Million |
| Free Cash Flow | RON-70.17 Million | RON-21.01 Million | RON24.42 Million | RON65.68 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | RON-15.95 Million | RON48.17 Million | RON-5.43 Million | RON2.00 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | RON53.00 Million | RON45.06 Million | RON27.93 Million | RON22.57 Million |
| Change in Cash | RON7.26 Million | RON619.91K | RON220.30K | RON52.83 Million |
Antibiotice Ia Earnings History — EPS Actual vs. Analyst Estimates
Track Antibiotice Ia's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 09, 2023 | 0.00 | 0.00 | — |
| Mar 01, 2023 | 0.06 | 0.00 | — |
| Nov 18, 2022 | 0.01 | 0.00 | — |
| Aug 12, 2022 | 0.02 | 0.00 | — |
| May 10, 2022 | 0.01 | 0.00 | — |
| Feb 23, 2022 | 0.04 | 0.00 | — |
| Nov 12, 2021 | 0.00 | 0.00 | — |
| Aug 13, 2021 | 0.02 | 0.00 | — |